COMBINED CLINICAL, VIRAL, AND IMMUNOLOGICAL STUDIES OF NEUROMUSCULAR DISEASES

神经肌肉疾病的临床、病毒和免疫学综合研究

基本信息

项目摘要

Clinical and laboratory studies are conducted to determine etiology (infection, immunity and/or genetics) of chronic diseases of the neuromuscular system and design effective therapies. Current studies involve patients with polymyositis/dermatomyositis, post-polio syndrome, amyotrophic lateral sclerosis (ALS), demyelinating polyneuropathies, neuromuscular diseases associated with HIV infection, hypokalemic periodic paralysis and Duchenne muscular dystrophy. The pathogenesis of post-polio syndrome is explored with a series of electrophysiological, virological, immunological and histological studies. The findings are compared with those seen in patients with acute paralytic poliomyelitis and other motor neuron diseases. Persistent or mutant poliovirus is sought in these patients' tissues using tissue cultures, PCR, and in situ hybridization. Because abnormal immunoregulation was found in some patients, a double-blind placebo-controlled trial using prednisone was conducted. The mechanism of post-polio fatigue, a common and disabling symptom in many patients, is examined by analysis of the neuroendocrine axis and by magnetic resonance spectroscopy. Sequence of the beta amyloid precursor protein gene is performed in patients with familial and sporadic inclusion body myositis. The spectrum of neuromuscular disorders associated with HIV infection has been studied and the role of the virus in the cause of neuropathy or myopathy is investigated with a variety of immunocytochemical studies, in situ hybridization and PCR. The antiretroviral drug AZT was found to cause a unique myopathy characterized by abnormal mitochondria as determined by various morphological, molecular, biochemical and immunocytochemical studies. A longitudinal study of HIV-positive patients that develop myopathic symptoms while on AZT is conducted with serial muscle biopsies to assess factors associated with the development of myopathy. Patients with AZT- myopathy were found to have low muscle carnitine level. This has prompted the conduction of an ongoing randomized controlled clinical trial using oral L- carnitine. Randomized-controlled clinical trials are conducted with high-dose Intravenous immunoglobulin in patients with polymyositis/dermatomyositis, chronic inflammatory and paraproteinemic demyelinating polyneuropathies, ALS, and Duchenne muscular dystrophy. A controlled study using dichlorophenamide, a carbonic anhydrase inhibitor, is also conducted in patients with hypokalemic periodic paralysis.
进行临床和实验室研究以确定病因 (感染、免疫力和/或遗传学) 神经肌肉系统和设计有效的治疗方法。目前的研究 涉及患有多发性肌炎/皮肌炎、脊髓灰质炎后综合征 肌萎缩侧索硬化症(ALS),脱髓鞘性多发性神经病, 与HIV感染相关的神经肌肉疾病,低钾血症 周期性麻痹和杜氏肌营养不良症。的发病机制 脊髓灰质炎后综合征是用一系列电生理学, 病毒学、免疫学和组织学研究。 这些发现是 与急性麻痹性脊髓灰质炎患者相比, 和其他运动神经元疾病。 持续性或突变型脊髓灰质炎病毒是 在这些患者的组织中使用组织培养,PCR和原位杂交, 杂交方法因为在一些人中发现了异常的免疫调节, 患者,使用泼尼松的双盲安慰剂对照试验, 进行。脊髓灰质炎后疲劳的机制,一种常见的和致残的 许多患者的症状,是通过分析神经内分泌检查 轴和磁共振光谱。 Beta的顺序 淀粉样前体蛋白基因在家族性和 散发性包涵体肌炎。 神经肌肉频谱 与艾滋病毒感染有关的疾病已经研究, 病毒在神经病或肌病的原因是调查与 各种免疫细胞化学研究,原位杂交和PCR。 抗逆转录病毒药物AZT被发现会导致一种独特的肌病 其特征在于通过各种方法确定的异常线粒体 形态学、分子生物学和免疫细胞化学研究。一 对发生肌病的HIV阳性患者的纵向研究 症状,而对AZT是进行了一系列肌肉活检,以评估 与肌病发展相关的因素。 AZT患者- 发现肌病患者肌肉肉毒碱水平较低。 这 促使进行一项正在进行的随机对照临床试验, 使用口服左旋肉碱的试验。随机对照临床试验是 高剂量静脉注射免疫球蛋白, 慢性炎症性和副蛋白血症性多发性肌炎/皮肌炎 脱髓鞘性多发性神经病、ALS和杜氏肌营养不良。一 使用二氯苯甲酰胺,一种碳酸酐酶抑制剂, 也在低钾性周期性麻痹患者中进行。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

M C DALAKAS其他文献

M C DALAKAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('M C DALAKAS', 18)}}的其他基金

NEUROMUSCULAR AND CENTRAL NERVOUS SYSTEM DISEASES AND THEIR EXPERIMENTAL MODELS
神经肌肉和中枢神经系统疾病及其实验模型
  • 批准号:
    3945253
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NEUROMUSCULAR AND CENTRAL NERVOUS SYSTEM DISEASES AND THEIR EXPERIMENTAL MODELS
神经肌肉和中枢神经系统疾病及其实验模型
  • 批准号:
    3846204
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NEUROMUSCULAR AND CNS DISEASES AND THEIR EXPERIMENTAL MODELS
神经肌肉和中枢神经系统疾病及其实验模型
  • 批准号:
    5203910
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NEUROMUSCULAR AND CENTRAL NERVOUS SYSTEM DISEASES AND THEIR EXPERIMENTAL MODELS
神经肌肉和中枢神经系统疾病及其实验模型
  • 批准号:
    3881732
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NEUROMUSCULAR AND CENTRAL NERVOUS SYSTEM DISEASES AND THEIR EXPERIMENTAL MODELS
神经肌肉和中枢神经系统疾病及其实验模型
  • 批准号:
    4696903
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NEUROMUSCULAR AND CNS DISEASES AND THEIR EXPERIMENTAL MODELS
神经肌肉和中枢神经系统疾病及其实验模型
  • 批准号:
    3760251
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
COMBINED CLINICAL, VIRAL, AND IMMUNOLOGICAL STUDIES OF NEUROMUSCULAR DISEASES
神经肌肉疾病的临床、病毒和免疫学综合研究
  • 批准号:
    3782296
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
COMBINED CLINICAL, VIRAL, AND IMMUNOLOGICAL STUDIES OF NEUROMUSCULAR DISEASES
神经肌肉疾病的临床、病毒和免疫学综合研究
  • 批准号:
    6162987
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NEUROMUSCULAR AND CNS DISEASES AND THEIR EXPERIMENTAL MODELS
神经肌肉和中枢神经系统疾病及其实验模型
  • 批准号:
    6111839
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
EVALUATION OF NEUROMUSCULAR DISEASES
神经肌肉疾病的评估
  • 批准号:
    6111918
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
  • 批准号:
    MR/Y014901/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
  • 批准号:
    MR/Y014286/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
  • 批准号:
    MR/Y503502/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
  • 批准号:
    2317745
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
  • 批准号:
    10696512
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
  • 批准号:
    10759808
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
  • 批准号:
    10848139
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
  • 批准号:
    10606865
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
  • 批准号:
    488892
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
  • 批准号:
    MR/Y001095/1
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了